{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:26:07Z","timestamp":1777307167695,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54 DK100227"],"award-info":[{"award-number":["U54 DK100227"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK083908"],"award-info":[{"award-number":["DK083908"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK101405"],"award-info":[{"award-number":["DK101405"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds:<\/jats:title>\n                    <jats:p>Previous studies have demonstrated that excretion of urinary extracellular vesicles (EVs) from different nephron segments differs between kidney stone formers and non-stone formers (NSFs), and could reflect pathogenic mechanisms of urinary stone disease. In this study we quantified selected populations of specific urinary EVs carrying protein markers of immune cells and calcium\/phosphorus physiology in calcium oxalate stone formers (CSFs) compared to non-stone formers (NSFs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Biobanked urine samples from CSFs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924) undergoing stone removal surgery and age- and sex- matched NSFs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200921) were studied. Urinary EVs carrying proteins related to renal calcium\/phosphorus physiology (phosphorus transporters (PiT1 and PiT2), Klotho, and fibroblast growth factor 23 (FGF23); markers associated with EV generation (anoctamin-4 (ANO4) and Huntington interacting protein 1 (HIP1)), and markers shed from activated immune cells were quantified by standardized and published method of digital flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Urine excretion of calcium, oxalate, phosphorus, and calcium oxalate supersaturation (SS) were significantly higher in CSFs compared to NSFs (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Urinary excretion of EVs with markers of total leukocytes (CD45), neutrophils (CD15), macrophages (CD68), Klotho, FGF23, PiT1, PiT2, and ANO4 were each markedly lower in CSFs than NSFs (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) whereas excretion of those with markers of monocytes (CD14), T-Lymphocytes (CD3), B-Lymphocytes (CD19), plasma cells (CD138 plus CD319 positive) were not different between the groups. Urinary excretion of EVs expressing PiT1 and PiT2 negatively (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) correlated with urinary phosphorus excretion, whereas excretion of EVs expressing FGF23 negatively (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) correlated with both urinary calcium and phosphorus excretion. Urinary EVs with markers of HIP1 and ANO4 correlated negatively (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) with clinical stone events and basement membrane calcifications on papillary tip biopsies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Urinary excretion of EVs derived from specific types of activated immune cells and EVs with proteins related to calcium\/phosphorus regulation differed between CSFs and NSFs. Further validation of these and other populations of urinary EVs in larger cohort could identify biomarkers that elucidate novel pathogenic mechanisms of calcium stone formation in specific subsets of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02417-8","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:34:29Z","timestamp":1622547269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium\/phosphorus physiology differ between calcium kidney stone formers and non-stone formers"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthuvel","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren P.","family":"Herrera Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Lieske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"1","key":"2417_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","volume":"62","author":"CD Scales Jr","year":"2012","unstructured":"Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Urologic Diseases in America P: Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160\u20135.","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"2417_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00240-014-0705-9","volume":"43","author":"SR Khan","year":"2015","unstructured":"Khan SR, Canales BK. Unified theory on the pathogenesis of Randall\u2019s plaques and plugs. Urolithiasis. 2015;43(Suppl 1):109\u201323.","journal-title":"Urolithiasis"},{"issue":"9","key":"2417_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301\u201320.","journal-title":"World J Urol"},{"issue":"3","key":"2417_CR4","first-page":"87","volume":"15","author":"AV Kustov","year":"2018","unstructured":"Kustov AV, Strelnikov AI. Quantitative Mineralogical Composition of Calculi and Urine Abnormalities for Calcium Oxalate Stone Formers: A Single-Center Results. Urol J. 2018;15(3):87\u201391.","journal-title":"Urol J"},{"key":"2417_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13293-015-0021-2","volume":"6","author":"M Jayachandran","year":"2015","unstructured":"Jayachandran M, Lugo G, Heiling H, Miller VM, Rule AD, Lieske JC. Extracellular vesicles in urine of women with but not without kidney stones manifest patterns similar to men: a case control study. Biology of sex differences. 2015;6:2.","journal-title":"Biology of sex differences"},{"issue":"7","key":"2417_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","volume":"158","author":"HA Fink","year":"2013","unstructured":"Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Ouellette J, Monga M. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158(7):535\u201343.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2417_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrneph.2017.10","volume":"13","author":"SR Mulay","year":"2017","unstructured":"Mulay SR, Anders HJ. Crystal nephropathies: mechanisms of crystal-induced kidney injury. Nature reviews Nephrology. 2017;13(4):226\u201340.","journal-title":"Nature reviews Nephrology"},{"issue":"4","key":"2417_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ar.22881","volume":"297","author":"AP Evan","year":"2014","unstructured":"Evan AP, Lingeman JE, Worcester EM, Sommer AJ, Phillips CL, Williams JC, Coe FL. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014;297(4):731\u201348.","journal-title":"Anat Rec (Hoboken)"},{"issue":"5","key":"2417_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI17038","volume":"111","author":"AP Evan","year":"2003","unstructured":"Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall\u2019s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003;111(5):607\u201316.","journal-title":"J Clin Invest"},{"issue":"4","key":"2417_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/ki.2013.189","volume":"84","author":"MP Linnes","year":"2013","unstructured":"Linnes MP, Krambeck AE, Cornell L, Williams JC Jr, Korinek M, Bergstralh EJ, Li X, Rule AD, McCollough CM, Vrtiska TJ, et al. Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int. 2013;84(4):818\u201325.","journal-title":"Kidney Int"},{"issue":"4 Pt 1","key":"2417_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.juro.2015.11.048","volume":"195","author":"S Kusmartsev","year":"2016","unstructured":"Kusmartsev S, Dominguez-Gutierrez PR, Canales BK, Bird VG, Vieweg J, Khan SR. Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages. J Urol. 2016;195(4 Pt 1):1143\u201351.","journal-title":"J Urol"},{"issue":"1","key":"2417_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion. J Clin Invest. 2013;123(1):236\u201346.","journal-title":"J Clin Invest"},{"key":"2417_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2018.00316","volume":"9","author":"N Singhto","year":"2018","unstructured":"Singhto N, Kanlaya R, Nilnumkhum A, Thongboonkerd V. Roles of Macrophage Exosomes in Immune Response to Calcium Oxalate Monohydrate Crystals. Front Immunol. 2018;9:316.","journal-title":"Front Immunol"},{"key":"2417_CR14","doi-asserted-by":"publisher","first-page":"204173141881013","DOI":"10.1177\/2041731418810130","volume":"9","author":"I Azoidis","year":"2018","unstructured":"Azoidis I, Cox SC, Davies OG. The role of extracellular vesicles in biomineralisation: current perspective and application in regenerative medicine. J Tissue Eng. 2018;9:2041731418810130.","journal-title":"J Tissue Eng"},{"key":"2417_CR15","doi-asserted-by":"publisher","first-page":"29642","DOI":"10.3402\/jev.v5.29642","volume":"5","author":"AE Turco","year":"2016","unstructured":"Turco AE, Lam W, Rule AD, Denic A, Lieske JC, Miller VM, Larson JJ, Kremers WK, Jayachandran M. Specific renal parenchymal-derived urinary extracellular vesicles identify age-associated structural changes in living donor kidneys. J Extracell Vesicles. 2016;5:29642.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"2417_CR16","doi-asserted-by":"publisher","first-page":"F1475-f1482","DOI":"10.1152\/ajprenal.00515.2018","volume":"317","author":"RS Chirackal","year":"2019","unstructured":"Chirackal RS, Jayachandran M, Wang X, Edeh S, Haskic Z, Perinpam M, Halling TM, Mehta R, Rivera ME, Lieske JC. Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls. American journal of physiology Renal physiology. 2019;317(6):F1475-f1482.","journal-title":"American journal of physiology Renal physiology"},{"issue":"9","key":"2417_CR17","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1681\/ASN.2013101066","volume":"25","author":"TF Hiemstra","year":"2014","unstructured":"Hiemstra TF, Charles PD, Gracia T, Hester SS, Gatto L, Al-Lamki R, Floto RA, Su Y, Skepper JN, Lilley KS, et al. Human urinary exosomes as innate immune effectors. Journal of the American Society of Nephrology: JASN. 2014;25(9):2017\u201327.","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"11","key":"2417_CR18","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1021\/acsnano.7b05083","volume":"11","author":"J Park","year":"2017","unstructured":"Park J, Lin HY, Assaker JP, Jeong S, Huang CH, Kurdi T, Lee K, Fraser K, Min C, Eskandari S, et al. Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection. ACS Nano. 2017;11(11):11041\u20136.","journal-title":"ACS Nano"},{"key":"2417_CR19","doi-asserted-by":"crossref","unstructured":"Chirackal RS, Jayachandran M, Wang X, Edeh S, Haskic Z, Perinpam M, Halling TM, Mehta R, Rivera ME, Lieske JC. Urinary extracellular vesicles associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls. American journal of physiology Renal physiology 2019.","DOI":"10.1152\/ajprenal.00515.2018"},{"issue":"6","key":"2417_CR20","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/S0022-5347(01)68153-9","volume":"158","author":"RK Low","year":"1997","unstructured":"Low RK, Stoller ML. Endoscopic mapping of renal papillae for Randall\u2019s plaques in patients with urinary stone disease. J Urol. 1997;158(6):2062\u20134.","journal-title":"J Urol"},{"key":"2417_CR21","doi-asserted-by":"crossref","unstructured":"Wang X, Krambeck AE, Williams JC Jr, Tang X, Rule AD, Zhao F, Bergstralh E, Haskic Z, Edeh S, Holmes DR 3. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall\u2019s plaque. Clin J Am Soc Nephrol. 2014;9(10):1757\u201363. rd et al.","DOI":"10.2215\/CJN.01490214"},{"issue":"1","key":"2417_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2015010074","volume":"27","author":"U Erdbrugger","year":"2016","unstructured":"Erdbrugger U, Le TH. Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers? Journal of the American Society of Nephrology: JASN. 2016;27(1):12\u201326.","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"16","key":"2417_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJM199210153271607","volume":"327","author":"FL Coe","year":"1992","unstructured":"Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327(16):1141\u201352.","journal-title":"N Engl J Med"},{"issue":"5","key":"2417_CR24","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/j.1523-1755.2005.00292.x","volume":"67","author":"M Daudon","year":"2005","unstructured":"Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005;67(5):1934\u201343.","journal-title":"Kidney Int"},{"issue":"2","key":"2417_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1523-1755.2003.00107.x","volume":"64","author":"MS Schepers","year":"2003","unstructured":"Schepers MS, Duim RA, Asselman M, Romijn JC, Schr\u00f6der FH, Verkoelen CF. Internalization of calcium oxalate crystals by renal tubular cells: a nephron segment-specific process? Kidney Int. 2003;64(2):493\u2013500.","journal-title":"Kidney Int"},{"issue":"6","key":"2417_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00240-010-0330-1","volume":"38","author":"AP Evan","year":"2010","unstructured":"Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010;38(6):439\u201352.","journal-title":"Urol Res"},{"issue":"1","key":"2417_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12894-018-0331-x","volume":"18","author":"A Okada","year":"2018","unstructured":"Okada A, Hamamoto S, Taguchi K, Unno R, Sugino T, Ando R, Mizuno K, Tozawa K, Kohri K, Yasui T. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. BMC Urol. 2018;18(1):19.","journal-title":"BMC Urol"},{"key":"2417_CR28","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fphar.2019.01192","volume":"10","author":"V Andrade-Oliveira","year":"2019","unstructured":"Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Camara NOS. Inflammation in Renal Diseases: New and Old Players. Front Pharmacol. 2019;10:1192.","journal-title":"Front Pharmacol"},{"key":"2417_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jprot.2018.06.015","volume":"185","author":"N Singhto","year":"2018","unstructured":"Singhto N, Thongboonkerd V. Exosomes derived from calcium oxalate-exposed macrophages enhance IL-8 production from renal cells, neutrophil migration and crystal invasion through extracellular matrix. Journal of proteomics. 2018;185:64\u201376.","journal-title":"Journal of proteomics"},{"issue":"1","key":"2417_CR30","doi-asserted-by":"publisher","first-page":"1400370","DOI":"10.1080\/20013078.2017.1400370","volume":"6","author":"C Wen","year":"2017","unstructured":"Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY. Biological roles and potential applications of immune cell-derived extracellular vesicles. Journal of extracellular vesicles. 2017;6(1):1400370.","journal-title":"Journal of extracellular vesicles"},{"key":"2417_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fimmu.2020.00074","volume":"11","author":"M Quaglia","year":"2020","unstructured":"Quaglia M, Dellepiane S, Guglielmetti G, Merlotti G, Castellano G, Cantaluppi V. Extracellular Vesicles as Mediators of Cellular Crosstalk Between Immune System and Kidney Graft. Front Immunol. 2020;11:74.","journal-title":"Front Immunol"},{"issue":"6","key":"2417_CR32","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.4049\/jimmunol.1101988","volume":"189","author":"L Lugini","year":"2012","unstructured":"Lugini L, Cecchetti S, Huber V, Luciani F, Macchia G, Spadaro F, Paris L, Abalsamo L, Colone M, Molinari A, et al. Immune surveillance properties of human NK cell-derived exosomes. Journal of immunology (Baltimore Md: 1950). 2012;189(6):2833\u201342.","journal-title":"Journal of immunology (Baltimore Md: 1950)"},{"issue":"5","key":"2417_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.yjmcc.2012.08.010","volume":"53","author":"Y Cheng","year":"2012","unstructured":"Cheng Y, Wang X, Yang J, Duan X, Yao Y, Shi X, Chen Z, Fan Z, Liu X, Qin S, et al. A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol. 2012;53(5):668\u201376.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"2417_CR34","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.bbagen.2009.09.006","volume":"1790","author":"EE Golub","year":"2009","unstructured":"Golub EE. Role of matrix vesicles in biomineralization. Biochim Biophys Acta. 2009;1790(12):1592\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"2417_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013;75:503\u201333.","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"2417_CR36","doi-asserted-by":"publisher","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","volume":"306","author":"J Gattineni","year":"2014","unstructured":"Gattineni J, Alphonse P, Zhang Q, Mathews N, Bates CM, Baum M. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. Am J Physiol Renal Physiol. 2014;306(3):F351\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2417_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.kint.2016.04.009","volume":"90","author":"N Ide","year":"2016","unstructured":"Ide N, Olauson H, Sato T, Densmore MJ, Wang H, Hanai JI, Larsson TE, Lanske B. In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling. Kidney international. 2016;90(2):348\u201362.","journal-title":"Kidney international"},{"issue":"2","key":"2417_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ymthe.2019.11.013","volume":"28","author":"C Grange","year":"2020","unstructured":"Grange C, Papadimitriou E, Dimuccio V, Pastorino C, Molina J, O\u2019Kelly R, Niedernhofer LJ, Robbins PD, Camussi G, Bussolati B. Urinary Extracellular Vesicles Carrying Klotho Improve the Recovery of Renal Function in an Acute Tubular Injury Model. Mol Ther. 2020;28(2):490\u2013502.","journal-title":"Mol Ther"},{"issue":"1","key":"2417_CR39","first-page":"15","volume":"3","author":"X Lu","year":"2017","unstructured":"Lu X, Hu MC. Klotho\/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. Kidney diseases (Basel Switzerland). 2017;3(1):15\u201323.","journal-title":"Kidney diseases (Basel Switzerland)"},{"issue":"17","key":"2417_CR40","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1093\/emboj\/20.17.5008","volume":"20","author":"C Raiborg","year":"2001","unstructured":"Raiborg C, Bache KG, Mehlum A, Stang E, Stenmark H. Hrs recruits clathrin to early endosomes. EMBO J. 2001;20(17):5008\u201321.","journal-title":"EMBO J"},{"issue":"7","key":"2417_CR41","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1074\/jbc.M408430200","volume":"280","author":"V Legendre-Guillemin","year":"2005","unstructured":"Legendre-Guillemin V, Metzler M, Lemaire JF, Philie J, Gan L, Hayden MR, McPherson PS. Huntingtin interacting protein 1 (HIP1) regulates clathrin assembly through direct binding to the regulatory region of the clathrin light chain. J Biol Chem. 2005;280(7):6101\u20138.","journal-title":"J Biol Chem"},{"issue":"19","key":"2417_CR42","doi-asserted-by":"publisher","first-page":"13305","DOI":"10.1074\/jbc.M113.457937","volume":"288","author":"J Suzuki","year":"2013","unstructured":"Suzuki J, Fujii T, Imao T, Ishihara K, Kuba H, Nagata S. Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J Biol Chem. 2013;288(19):13305\u201316.","journal-title":"J Biol Chem"},{"key":"2417_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-physiol-022516-034031","volume":"79","author":"JM Whitlock","year":"2017","unstructured":"Whitlock JM, Hartzell HC. Anoctamins\/TMEM16 Proteins: Chloride Channels Flirting with Lipids and Extracellular Vesicles. Annu Rev Physiol. 2017;79:119\u201343.","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"2417_CR44","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1042\/CS20171574","volume":"132","author":"A Devarajan","year":"2018","unstructured":"Devarajan A. Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases. Clin Sci (Lond). 2018;132(6):615\u201326.","journal-title":"Clin Sci (Lond)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02417-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:36:07Z","timestamp":1622547367000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02417-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2417"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02417-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-64903\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board at Mayo Clinic, Rochester Minnesota, USA and written consent was obtained from study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from study participants to publish specific images and clinical details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest or competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}